Sponsor pipeline

Haisco Pharmaceutical Group Co., Ltd. clinical trial pipeline

Get alerts when Haisco Pharmaceutical Group Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
15
Phase 1/2
2
Phase 2
18
Phase 3
11
Phase 4
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 14

COPD (8) · Idiopathic Pulmonary Fibrosis (3) · Psoriasis (3) · Asthma (2) · Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Colorectal Cancer (1) · Diabetes (1) · Lupus (SLE) (1) · NASH / MASH (1)

Get alerts when Haisco Pharmaceutical Group Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free